4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015819
SVP, Chief Accounting Officer sold 843 shares at $66.62 ($56,161)
- SVP, Chief Accounting Officer acquired 3,710 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Sale : show line 1 in the form | −843 | $66.62 | $56,161 | 13,229 | D |
| 2022-03-01 | Grant or award : show line 2 in the form | +3,710 | 17,046 | D | ||
| Open-market sales · 843 sh · avg $66.62 · $56,161 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +7,400 | 7,400 | D |
Loading xslF345X03/doc4.xml…